US FDA rejects Neurotech application for orphan drug status by Steve Jones October 8, 2024February 25, 2025 The US Food and Drug Administration (FDA) has rejected an application from Neurotech International to grant […]
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing by Steve Jones June 28, 2024June 28, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
